A step backwards in the fight against global vaccine inequities
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-12-31
Type
Journal Article
Author
Ernest Aryeetey
Author
Eivind Engebretsen
Author
Åse Gornitzka
Author
Peter Maassen
Author
Svein Stølen
URL
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32596-4/abstract
Publication
The Lancet
ISSN
0140-6736, 1474-547X
Date
09/12/2020
Extra
Publisher: Elsevier
PMID: 33308424
Journal Abbr
The Lancet
DOI
10.1016/S0140-6736(20)32596-4
Library Catalog
www.thelancet.com
Language
English
Abstract
The news that an effective vaccine against severe acute respiratory syndrome coronavirus
2 will be introduced imminently was welcomed with great enthusiasm worldwide. The
consensus is that access to vaccines for low-income countries is a global responsibility.1
To make sure that all countries and their citizens will have equal access to a vaccine,
Eswatini, India, Kenya, and South Africa proposed a waiver2 from certain provisions
of the Agreement on Trade-Related Aspects of Intellectual Property Rights by the World
Trade Organization.